Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
5.00
+0.50 (11.11%)
Aug 13, 2025, 4:00 PM - Market closed
Corvus Pharmaceuticals Market Cap
Corvus Pharmaceuticals has a market cap or net worth of $372.57 million as of August 14, 2025. Its market cap has increased by 108.26% in one year.
Market Cap
372.57M
Enterprise Value
299.25M
1-Year Change
108.26%
Ranking
Category
Stock Price
$5.00
Market Cap Chart
Since March 23, 2016, Corvus Pharmaceuticals's market cap has increased from $290.80M to $372.57M, an increase of 28.12%. That is a compound annual growth rate of 2.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 372.60M | 8.38% |
| Dec 31, 2024 | 343.80M | 298.38% |
| Dec 29, 2023 | 86.30M | 117.93% |
| Dec 30, 2022 | 39.60M | -64.71% |
| Dec 31, 2021 | 112.20M | 12.31% |
| Dec 31, 2020 | 99.90M | -37.56% |
| Dec 31, 2019 | 160.00M | 48.84% |
| Dec 31, 2018 | 107.50M | -50.69% |
| Dec 29, 2017 | 218.00M | -27.09% |
| Dec 30, 2016 | 299.00M | 2.82% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |